少用量水化物抑制剤の世界市場

◆英語タイトル:Low Dosage Hydrate Inhibitors - Global Market Outlook (2015-2022)
◆商品コード:SMRC65120
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年4月
◆ページ数:129
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:材料
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥460,650見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥582,750見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、少用量水化物抑制剤の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・少用量水化物抑制剤の世界市場:種類別分析/市場規模
・少用量水化物抑制剤の世界市場:地域別分析/市場規模
・少用量水化物抑制剤のアメリカ市場規模予測
・少用量水化物抑制剤のヨーロッパ市場規模予測
・少用量水化物抑制剤のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Low Dosage Hydrate Inhibitors Market is valued at $XX billion in 2015 and is projected to reach $XX billion by 2022 growing at a CAGR of XX% from 2015 to 2022. Increasing research applications and growing demand for high consumption of crude oil are some of the key factors driving the market growth. Population growth and industrialization are some of the key drivers in this market growth. Furthermore, growing population and rapid industrialization generate an increase in demand of energy. Increasing energy demand leads to higher production of oil which in turn, leads to the growth of low dosage hydrate inhibitors. However, cost effective, continuous fabrication of crude oil and low dosage hydrate inhibitor usage are the restraints hampering this market growth. North American region is expected to register a significant growth for these products over the forecast period.
Some of the key players in the market include Ashland, Halliburton and NALCO (ECOLAB COMPANY), NEFTECHIM Technologies, JSC Gazprom Neftekhim Salavat, Clariant Chemicals, GasHydrate LLC, Evonik, Ecolab, ClariantOilServices, Yara International, Stella Maris LLC, LEWA ,Woodview Technology and BASF.

Basis Covered:
• Anti-Agglomerate (AA) inhibitors
• Kinetic Hydrate Inhibitors (KHI)

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Low Dosage Hydrate Inhibitors Market, By Basis
5.1 Introduction
5.2 Anti-Agglomerate (AA) inhibitors
5.3 Kinetic Hydrate Inhibitors (KHI)

6 Global Low Dosage Hydrate Inhibitors Market, By Geography
6.1 North America
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.2.6 Rest of Europe
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 India
6.3.4 Australia
6.3.5 New Zealand
6.3.6 Rest of Asia Pacific
6.4 Rest of the World
6.4.1 Middle East
6.4.2 Brazil
6.4.3 Argentina
6.4.4 South Africa
6.4.5 Egypt

7 Key Developments
7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies

8 Company Profiling
8.1 Ashland
8.2 Halliburton
8.3 NALCO (ECOLAB COMPANY)
8.4 Woodview Technology
8.5 BASF
8.6 NEFTECHIM Technologies
8.7 JSC Gazprom Neftekhim Salavat
8.8 Clariant Chemicals
8.9 GasHydrate LLC
8.10 Evonik
8.11 Ecolab
8.12 ClariantOilServices
8.13 Yara International
8.14 Stella Maris LLC
8.15 LEWA

List of Tables
Table 1 Global Low Dosage Hydrate Inhibitors Market Outlook, By Region (2015-2022) ($MN)
Table 2 Global Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 3 Global Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 4 Global Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)
Table 5 North America Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 6 North America Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 7 North America Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)
Table 8 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 9 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 10 Europe Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)
Table 11 Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 12 Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 13 Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)
Table 14 Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Basis (2015-2022) ($MN)
Table 15 Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (2015-2022) ($MN)
Table 16 Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (2015-2022) ($MN)



【レポートのキーワード】

水化物抑制剤

★調査レポート[少用量水化物抑制剤の世界市場]販売に関する免責事項
★調査レポート[少用量水化物抑制剤の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆